Scarica l'app Stockscreener
19.21
29.01%
4.32
Dopo l'orario di chiusura:
18.72
-0.49
-2.55%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Arcturus Therapeutics Holdings Inc Borsa (ARCT) Ultime notizie
Intapp Posts Better-Than-Expected Earnings, Joins Sapiens International, Arcturus Therapeutics, Gildan Activewear And Other Big Stocks Moving Higher On Wednesday - Benzinga
Arcturus Therapeutics (NASDAQ:ARCT) Upgraded at Wall Street Zen - MarketBeat
William Blair Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating - 富途牛牛
Mercury Systems Posts Better-Than-Expected Earnings,… - inkl
Wells Fargo lowers Arcturus Therapeutics stock price target to $42 on model updates - Investing.com Canada
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress - BioSpace
Arcturus Therapeutics Reports Q2 2025 Earnings and Pipeline Progress - TipRanks
Arcturus Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
Arcturus Therapeutics Holdings Inc earnings missed by $3.55, revenue fell short of estimates - Investing.com Nigeria
Transcript : Arcturus Therapeutics Holdings Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
Arcturus Tightens Its Belt As Analysts Stay Bullish - Finimize
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Arcturus Therapeutics Q2 2025 results miss expectations - Investing.com
Arcturus Therapeutics Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Arcturus Therapeutics Q2 net loss narrows - MarketScreener
Arcturus Therapeutics shares edge higher despite earnings miss in Q2 By Investing.com - Investing.com Australia
Short interest data insights for Arcturus Therapeutics Holdings Inc.Historical Market Behavior and Trend Summary - Newser
Risk vs reward if holding onto Arcturus Therapeutics Holdings Inc.Swing Trade Timing with Daily Forecast - Newser
Multi factor analysis applied to Arcturus Therapeutics Holdings Inc.High Yield Signals with Entry Timing - Newser
Arcturus Therapeutics Q2 2025 Earnings Preview: Analysts Expect EPS of -$0.87, Revenue of $18.71M. - AInvest
Arcturus Therapeutics Stock Rises After Promising Mid-Stage Data for OTC Deficiency Treatment - MSN
Arcturus Therapeutics Holdings Inc expected to post a loss of 89 cents a shareEarnings Preview - TradingView
What To Expect From Arcturus Therapeutics Holdings Inc (ARCT) Q2 2025 Earnings - GuruFocus
Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034 - GlobeNewswire Inc.
Is Arcturus Therapeutics Holdings Inc. stock overvalued or undervaluedHigh-yield portfolio picks - Jammu Links News
What is the risk reward ratio of investing in Arcturus Therapeutics Holdings Inc. stockRapid return acceleration - Jammu Links News
How does Arcturus Therapeutics Holdings Inc. compare to its industry peersFree Risk Assessment Services - Jammu Links News
What are analysts’ price targets for Arcturus Therapeutics Holdings Inc. in the next 12 monthsBuild a winning investment portfolio - Jammu Links News
When is Arcturus Therapeutics Holdings Inc. stock expected to show significant growthDiscover breakthrough stocks before the crowd - Jammu Links News
Is Arcturus Therapeutics Holdings Inc. a growth stock or a value stockGet professional guidance for market timing - Jammu Links News
What catalysts could drive Arcturus Therapeutics Holdings Inc. stock higher in 2025Get alerts on high-potential stock breakouts - Jammu Links News
What drives Arcturus Therapeutics Holdings Inc. stock priceAchieve rapid financial growth with smart picks - Jammu Links News
What is Arcturus Therapeutics Holdings Inc. company’s growth strategyTremendous financial leverage - Jammu Links News
What are Arcturus Therapeutics Holdings Inc. company’s key revenue driversRapid return acceleration - Jammu Links News
Arcturus Therapeutics Holdings Inc expected to post a loss of 90 cents a shareEarnings Preview - TradingView
Investors Don't See Light At End Of Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Tunnel - 富途牛牛
High Growth US Tech Stocks To Watch In August 2025 - simplywall.st
Can Arcturus Therapeutics Holdings Inc. hit a new high this monthWeekly Stock Opportunity Radar Scanner Activated - metal.it
Is Arcturus Therapeutics Holdings (NASDAQ:ARCT) Weighed On By Its Debt Load? - simplywall.st
Why is Arcturus Therapeutics Holdings Inc. stock attracting strong analyst attentionBeginner Investor Report With Low Risk - Jammu Links News
Arcturus Therapeutics Holdings Inc. Sees Relief Buying After Extended DropValue Investing Picks With Stability Outlined - beatles.ru
Published on: 2025-07-29 23:05:26 - metal.it
Sector ETF Data Correlates with Strength in Arcturus Therapeutics Holdings Inc.Investment Playbook for Growing Markets Shared - metal.it
Using R and stats models for Arcturus Therapeutics Holdings Inc. forecastingFree Real-Time Analysis With Entry Targets - Newser
Price Floor Holding on Arcturus Therapeutics Holdings Inc. — Rebound PossibleSmart Investment Tips Gaining Popularity Among Analysts - metal.it
How Arcturus Therapeutics Holdings Inc. stock performs during market volatilityCapital Growth Summary Over Five Years - Newser
Arcturus Therapeutics Holdings Inc. Shows Risk Reward Favoring UpsideGrowth Focused Entry Plan Suggestions Issued - metal.it
Does Arcturus Therapeutics Holdings Inc. stock perform well during market downturnsFree Stock Market Real-Time Monitoring - Jammu Links News
Why Arcturus Therapeutics Holdings Inc. stock attracts strong analyst attentionTrading Volume Anomaly Summary and Insight - Newser
New York State Common Retirement Fund Sells 1,100 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):